Pricing Log in Create free account

Innate Pharma S.A. Sponsored ADR (IPHA) vs Veraxa Biotech AG (VRXA)

Innate Pharma S.A. Sponsored ADR and Veraxa Biotech AG are both Biotechnology companies. Innate Pharma S.A. Sponsored ADR and Veraxa Biotech AG are of similar size ($165.3M and $162.5M).

Valuation

Metric IPHA VRXA Biotechnology median
P/E n/m — 8.50
P/S n/m — 9.71
P/B n/m — 2.13
Price to free cash flow n/m — 20.82
EV/EBITDA n/m — 0.64
EV/Sales 0.12 — 9.21
Earnings yield (81.58%) — (33.15%)
Free cash flow yield 0.00% — (25.50%)

Profitability

Metric IPHA VRXA Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin (99.70%) — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity 0.00% — (56.36%)
Return on assets 0.00% — (48.04%)
Return on invested capital 0.00% — 0.00%

Growth

Metric IPHA VRXA Biotechnology median
Revenue growth (TTM) (4.17%) — 6.02%
EPS growth (last fiscal year) 6.06% — 30.26%
Revenue growth, 5-year CAGR (33.86%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IPHA VRXA Biotechnology median
Debt to equity (0.50) — 0.00
Current ratio 0.60 — 4.72
Net debt to EBITDA 0.22 — 0.96

Dividend

Metric IPHA VRXA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IPHA VRXA Biotechnology median
Market cap 165.32m 162.50m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack